High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (5) , 802-808
- https://doi.org/10.1161/01.atv.0000066134.79956.58
Abstract
Objective— Plasma high density lipoprotein (HDL) levels have been shown to be inversely correlated with coronary artery disease, but the mechanisms of the direct protective effect of HDL on endothelial cells (ECs) are not fully understood. In this study, we investigated the role of the HDL-mediated promotion of angiogenesis in human coronary artery ECs (HCECs). Methods and Results— We developed an in vitro model of HCEC tube formation on a matrix gel. We optimized the maximum dose of HDL required to induce tube formation in initial experiments, in which the dose response showed that the maximum effective dose of HDL was 100 μg/mL. PD98059, an inhibitor of p42/44 mitogen-activated protein kinase (MAPK) activity, but not SB203580, an inhibitor of p38 MAPK activity, suppressed HDL-induced tube formation. Dominant-negative Ras N17 inhibited HDL-induced tube formation. HDL activated Ras according to a ras pull-down assay, and this effect was inhibited by pertussis toxin. Moreover, HDL activated phospho(p)-p42/44 MAPK, whereas Ras N17 blocked HDL-induced pp42/44 MAPK. Conclusions— These results indicate that HDL induced a potent signal through a Ras/MAPK pathway mediated by a pertussis toxin–sensitive G-protein coupled receptor to the angiogenic phenotype in HCECs.Keywords
This publication has 20 references indexed in Scilit:
- Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras ActivationJournal of Biological Chemistry, 2001
- Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated LysosphingolipidsJournal of Biological Chemistry, 2001
- Sphingosine 1-Phosphate May Be a Major Component of Plasma Lipoproteins Responsible for the Cytoprotective Actions in Human Umbilical Vein Endothelial CellsJournal of Biological Chemistry, 2001
- ‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examplesEuropean Journal Of Cancer, 2000
- High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced ApoptosisBiochemical and Biophysical Research Communications, 2000
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsOncogene, 1998
- Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cellsAtherosclerosis, 1996
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Basement membrane complexes with biological activityBiochemistry, 1986